Ovarian cancer
Conditions
Interventions
Pathological Complete Response:None
Non Pathological Complete Response:None
Sponsors
Shengjing Hospital of China Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Age >=18 years old; 2) Patients with ovarian cancer diagnosed by histopathological biopsy; 3) Patients with clear staging by the FIGO International staging method; 4) No history of other malignant tumors before neoadjuvant therapy; 5) No surgical, chemotherapy or targeted therapy has been received within the three months prior to neoadjuvant therapy
Exclusion criteria
Exclusion criteria: 1) Other related metabolic diseases such as hyperglycemia, hyperlipidemia, and thyroid dysfunction; 2) Did not undergo intervaldebulking surgery after neoadjuvant chemotherapy; 3) Receiving surgery performed in another hospital and unobtainable intraoperative results; 4) Obvious pelvic inflammation, other major diseases and systemic inflammation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Metabolic profile;Metabolic characteristics;Metabolite concentration; | — |
Countries
China
Contacts
Public ContactXin Zhou; Xinyue Li
Shengjing Hospital of China Medical University
Outcome results
None listed